Athero Review - Issue Supplementum 2/2021
7
01ÚS Labetalol treatment exacerbates estrogen-induced liver damage
Igreja E Sá Ic, Faradonbeh Fa, Hroch M, Lastuvkova H, Tripska K, Pericacho M, Micuda S, Nachtigal P
16
19ÚS Soluble endoglin: Anything new and interesting?
Nachtigal P, Igreja E Sá Ic, Tripska K, Vitverová B, Najmanová I, Eissazadeh S, Víšek J, Bláha M, Blaha V, Micuda S
23
33PS Endoglin blockage is essential in hypercholesterolemia and hyperglycemia induced endothelial dysfunction in HAECs
Tripska K, Igreja E Sá Ic, Vicen M, Havelek R, Eissazadeh S, Vitverová B, Nachtigal P
Athero Review
2021 Issue Supplementum 2
Most read in this issue
- 01ÚS Labetalol treatment exacerbates estrogen-induced liver damage
- 19ÚS Soluble endoglin: Anything new and interesting?
- 33PS Endoglin blockage is essential in hypercholesterolemia and hyperglycemia induced endothelial dysfunction in HAECs